JAN 18, 2022 8:00 AM PST

Omicron Can't Dodge T Cells

WRITTEN BY: Tara Fernandes

The Omicron variant was first reported in November 2021. More recently, a surge of infections worldwide has led to widespread concern around how easily the variant spreads and how it can evade vaccines, immune defenses, and antibody-based COVID treatments.

Omicron’s ability to sidestep pandemic countermeasures results from its many mutations. Scientists have identified over 30 mutations in the region encoding the spike protein of SARS-CoV-2, which could explain why the efficacy of antibodies targeting earlier variants has begun to wane.

Now, researchers are interested in understanding other immune system elements that are impacted by Omicron infections. Interestingly, they’re finding that while antibodies may be losing their potency, T cell responses have remained effective against Omicron.

T cell antiviral responses have been somewhat overlooked over the course of the pandemic, but they can limit the risk of COVID symptoms escalating. They can recruit other immune cells and kill cells that have been infected by viruses. Interestingly, T cell responses stay elevated long after antibody levels have naturally tapered off. Moreover, T cells recognize larger target areas on the spike protein, meaning that they can still evoke a robust response even in the presence of mutations.

Several studies have released findings supporting the hypothesis that T cells can still recognize and neutralize Omicron. Data from lab-based assays and computational analyses found that most known T cell recognition sites on the spike protein have remained unchanged in Omicron.

In addition, scientists analyzed T cells from vaccinated individuals, and those that have recovered from COVID can produce strong responses to Omicron.

With more variants of SARS-CoV-2 likely to emerge in time, researchers are taking a closer look at how they can harness T cell activity to prevent the onset of severe symptoms.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
FEB 03, 2022
Immunology
Nanoparticles Act Like Platelets to Stop Bleeding
FEB 03, 2022
Nanoparticles Act Like Platelets to Stop Bleeding
  Researchers have created nanoparticles that mimic the effects of blood platelets to stop heavy bleeding. Biomedic ...
FEB 20, 2022
Health & Medicine
Effective Covid-19 Multidrug Treatment Using Repurposed Time-Tested and Inexpensive Drugs
FEB 20, 2022
Effective Covid-19 Multidrug Treatment Using Repurposed Time-Tested and Inexpensive Drugs
Ivermectin has been a drug of controversy in the COVID-19 treatment debate. Last year, it got a bad rap from the mainstr ...
MAR 01, 2022
Immunology
How an Emerging Pathogen Takes Control of Host Immunity
MAR 01, 2022
How an Emerging Pathogen Takes Control of Host Immunity
Bacteria called Legionella are commonly found in the environment, and they love to live in hot water. They can also caus ...
MAR 29, 2022
Immunology
A Master Regulator That Helps Power Immune Cells on the Attack
MAR 29, 2022
A Master Regulator That Helps Power Immune Cells on the Attack
When pathogens infect cells, the immune system has to launch a counterattack. Researchers have now learned more about ho ...
APR 12, 2022
Plants & Animals
Fiber Could Reduce Inflammation. But What Kind of Fiber is Best?
APR 12, 2022
Fiber Could Reduce Inflammation. But What Kind of Fiber is Best?
Dietary fiber is an important component of a healthy diet. As a carbohydrate that can’t be digested by the body, i ...
MAY 15, 2022
Health & Medicine
Virus-Infected Pig Heart Transplanted Into a Human
MAY 15, 2022
Virus-Infected Pig Heart Transplanted Into a Human
The University of Maryland School of Medicine reached a medical milestone this year when it transplanted a genetically-e ...
Loading Comments...